What is the market doing?
What the tape says about URGN
UroGen Pharma Ltd. is +147% over the past year while the S&P 500 is +23%: 124 points ahead of the market.
+147%
1-year return · S&P 500 +23%
- vs 200-day average
- +73%
vs 200-day average · a clear uptrend
- RSI (14)
- 51
RSI (14) · neutral
- Below its 52-week high
- −8.7%
Below its 52-week high
Details›
- Last close2026-08-26
- $45.91
- 1 monthS&P 500 +3.7%
- +7.9%
- 1 yearS&P 500 +23%
- +147%
- 5 yearsS&P 500 +87%
- +194%
- vs 50-day average$38.83
- +18%
- 52-week high
- $50.29
- 52-week low
- $16.42
- Annualised volatility
- 89%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$435K
| Year | Return |
|---|---|
| 2026 (year to date) | +96% |
| 2025 | +120% |
| 2024 | −29% |
| 2023 | +69% |
| 2022 | −6.7% |
| 2021 | −47% |
| 2020 | −46% |
| 2019 | −23% |
| 2018 | +16% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 9 | 5 of 9 | +3.2% |
| Feb | 9 | 3 of 9 | −3.4% |
| Mar | 9 | 3 of 9 | −2.8% |
| Apr | 9 | 5 of 9 | +7.9% |
| May | 9 | 3 of 9 | −10% |
| Jun | 10 | 8 of 10 | +32% |
| Jul | 10 | 5 of 10 | +13% |
| Aug | 10 | 6 of 10 | +4.0% |
| Sep | 9 | 3 of 9 | −4.7% |
| Oct | 9 | 5 of 9 | +2.3% |
| Nov | 9 | 6 of 9 | +9.6% |
| Dec | 9 | 3 of 9 | −7.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.